A database of pharmacy practice guidelines

Equations and Calculators

A reference of common clinical pharmacokinetic and metabolic equations for use in acute and ambulatory care settings. Formulas are organized by clinical category. Normal reference ranges are noted where applicable.

⚠️ These equations are clinical tools. Always interpret results in the context of the full clinical picture. Treat the patient as a whole, not the number.

Metabolic

Equation Formula Notes
Anion Gap nl 8–12 Na − (Cl + HCO₃) Elevated AG suggests organic acidosis (MUDPILES). Correct for albumin: AG + 2.5×(4 − Albumin)
Calculated Osmoles (2×Na) + (Glu/18) + (BUN/2.8) + (EtOH/4.6)
Osmolal Gap nl <10 Measured Osm − Calculated Osm Elevated gap suggests toxic alcohols (methanol, ethylene glycol, isopropanol)
Corrected Na hyperglycemia Measured Na + 2.4 × (Glu − 100) ÷ 100 Some guidelines use 1.6 mEq/L per 100 mg/dL; 2.4 preferred at higher glucose levels
Corrected Ca hypoalbuminemia Ca + 0.8 × (4 − Albumin) Only for total calcium; use ionized Ca when available in critically ill

Renal Function

Equation Formula Notes
CrCl (Cockcroft-Gault) [(140 − age) × Wt (kg)] ÷ [SCr × 72] × 0.85♀ Use ABW in obesity if ABW < IBW; use IBW or adjusted BW otherwise. Standard for drug dosing
FENa Pre-renal <1% (UNa × PCr) ÷ (PNa × UCr) × 100 Intrinsic renal >2%; unreliable if diuretics given. Use FEUrea instead: <35% = pre-renal
Total Body Water (TBW) Wt (kg) × 0.6 Use 0.5 for female/elderly; 0.6 for infants. Used in sodium correction formulas

Sodium Disorders

Equation Formula Notes
Δ[Na]/L infusate Hyponatremia ([Na]inf − [Na]serum) ÷ (TBW + 1) Adrogue-Madias equation. Max correction: ≤10–12 mEq/L per 24h to prevent osmotic demyelination
Rate of Infusion Hyponatremia 1000 × TBW × (desired Na − serum Na) ÷ ([Na]inf × time (h)) Result in mL/h. Reassess frequently — TBW and Na are dynamic
Free Water Deficit Hypernatremia TBW × [(Serum Na ÷ 140) − 1] Replace deficit slowly: max 10 mEq/L/24h correction to avoid cerebral edema
Δ[Na]/L infusate Hypernatremia ([Na]inf + [K]inf − [Na]serum) ÷ (TBW + 1) Accounts for potassium content of infusate (e.g., LR, NS with KCl). Negative value = lowers Na
Total Infusion Volume Hypernatremia (Desired Na − Serum Na) ÷ Δ[Na]/L infusate Result in liters. Rate = total (mL) ÷ 24h

Pharmacokinetics

Parameter Formula Notes
Volume of Distribution (Vd) Total drug in body ÷ Plasma concentration (Cp) Units: L or L/kg. High Vd = extensive tissue distribution
Half-life (t½) 0.693 × Vd ÷ CL Steady state reached in ~4–5 half-lives
Loading Dose Vd × Target Cp ÷ F F = bioavailability (1.0 for IV). Used to rapidly achieve therapeutic levels
Maintenance Dose CL × Target Css × τ ÷ F τ = dosing interval; Css = target steady-state concentration
Clearance (CL) Dose × F ÷ AUC CL = CLrenal + CLhepatic. Units: L/h or mL/min
Elimination Rate Constant (Ke) ln(C₁/C₂) ÷ Δt C₁ and C₂ are concentrations at times t₁ and t₂; Ke = 0.693 ÷ t½

Hepatic/Nutrition

Equation Formula Notes
Child-Pugh Score Bili + INR + Albumin + Ascites + Encephalopathy Class A = 5–6 pts, B = 7–9, C = 10–15. Guides drug dosing in hepatic impairment
Harris-Benedict (Male) 66 + (13.7×W) + (5×H) − (6.8×age) W in kg, H in cm. Multiply by activity/stress factor (1.2–2.0) for total energy needs
Harris-Benedict (Female) 655 + (9.6×W) + (1.8×H) − (4.7×age) Same units and stress factor as male equation

Pediatric

Equation Formula Notes
Fluid Maintenance 4-2-1 Rule 4 mL/kg/h (1st 10 kg) + 2 mL/kg/h (2nd 10 kg) + 1 mL/kg/h (remainder) Daily equivalent: 100/50/20 mL/kg/day. Adjust for clinical status and insensible losses
BSA — Mosteller √[ Ht (cm) × Wt (kg) ÷ 3600 ] Result in m². Used for chemotherapy and weight-sensitive dosing in pediatrics and oncology
IBW (Children) (Age × 2) + 8 Approximation for ages 1–12 years in kg. Not applicable to infants or adolescents

Clinical Calculators

If you found this resource helpful and would like to support ongoing updates, consider contributing at BuyMeACoffee or Venmo @pharmguides.

Buy me a coffee

References: Lexicomp Online; Dipiro's Pharmacotherapy, 12th ed.; Winter's Basic Clinical Pharmacokinetics, 6th ed. Accessed April 2026.

This resource is intended for educational and reference purposes only. It is not a substitute for clinical judgment. Institutional policies, protocols, and locally approved guidelines take precedence over the information presented here. Clinicians should always consult their own institution’s policies and applicable references before making therapeutic decisions.